NewsEventsReports
NewsEventsReports
Submit Content
Get the latest delivered to your inbox
Privacy Policy
  1. Home
  2. /
  3. Members
  4. /
  5. Merck & Co., Inc.

Merck & Co., Inc.

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.

    Merck & Co. Is Honored to Be Named to Forbes America's Best Employers List for the Eighth Year in a Row. Image

    POSTED 

    02-25-22

    Merck & Co. Is Honored to Be Named to Forbes America's Best Employers List for the Eighth Year in a Row.

    Merck & Co. Is honored to have been named to Forbes America's Best Employers list for the eighth year in a row!
    Why This New Dad Says Every Company Should Offer Parental Leave Image

    POSTED 

    02-23-22

    Why This New Dad Says Every Company Should Offer Parental Leave

    Steve Pribis was ecstatic when he learned our company’s paid parental leave extended to 12 weeks­­ in January 2021.
    Merck to Hold Event to Discuss Long-Term Environmental, Social & Governance Priorities Image

    POSTED 

    02-17-22

    Merck to Hold Event to Discuss Long-Term Environmental, Social & Governance Priorities

    Merck (NYSE: MRK), known as MSD outside the United States and Canada, provided additional details today of the company’s virtual Investor Event in which its senior management team will discuss Environmental, Social & Governance (ESG) priorities.
    3 Ways to Advance Cancer Health Care Equity Image

    POSTED 

    02-16-22

    3 Ways to Advance Cancer Health Care Equity

    Everyone deserves an equal opportunity to achieve their full health potential, and that includes access to cancer care.
    Paying Tribute to Our Black Leaders in Science Image

    POSTED 

    02-09-22

    Paying Tribute to Our Black Leaders in Science

    Throughout our company’s history, diversity and inclusion has fueled our mission to help save and improve lives.
    This Leader Works To Ensure Diversity and Inclusion Is Visible in Everything We Do Image

    POSTED 

    02-04-22

    This Leader Works To Ensure Diversity and Inclusion Is Visible in Everything We Do

    Deepak Khanna, president, Europe and Canada, demonstrates how “diversity is a fact, but inclusion is an act”
    Giving Back: How Our Pro Bono Program Drives Positive Change Image

    POSTED 

    02-02-22

    Giving Back: How Our Pro Bono Program Drives Positive Change

    Jennifer Zachary, Merck’s General Counsel, on how we can provide more legal services to those in need
    Our Disability Inclusiveness Earns Top Employer Award Image

    POSTED 

    01-26-22

    Our Disability Inclusiveness Earns Top Employer Award

    In recognition of our commitment to disability inclusiveness, Disability:IN has presented us with the 2020 Employer of the Year Award.
    Merck Scientists Launch Research Award to Support Rising Chemists of Color Image

    POSTED 

    01-19-22

    Merck Scientists Launch Research Award to Support Rising Chemists of Color

    The new Merck Research Award for Underrepresented Chemists of Color adds to our company’s efforts to promote diversity, inclusion and equity in all that we do.
    Merck and Ridgeback Announce Supply Agreement With UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine Image

    POSTED 

    01-18-22

    Merck and Ridgeback Announce Supply Agreement With UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine

    Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the signing of a long-term supply agreement with the United Nations Children’s Fund (UNICEF) to facilitate broad global access for molnupiravir, an investigational oral antiviral COVID...
    Merck & Co., Inc. Logo

    Merck & Co., Inc.

    Merck & Co., Inc.

    Can't find what you're looking for?

    Join today and get the latest delivered to your inbox

    Privacy Policy